| Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders (NCT00258258) | Roswell Park Cancer Institute | 2005-08-01 |
| Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant (NCT00288028) | Barbara Ann Karmanos Cancer Institute | 2005-07-01 |
| Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer (NCT00611351) | University of Nebraska | 2005-06-07 |
| Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00245037) | OHSU Knight Cancer Institute | 2005-06-01 |
| Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00477750) | Mayo Clinic | 2005-06-01 |
| Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma (NCT00477815) | Mayo Clinic | 2005-05-31 |
| Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia (NCT00258245) | Barbara Ann Karmanos Cancer Institute | 2005-05-01 |
| Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain (NCT00666211) | Vanderbilt-Ingram Cancer Center | 2005-05-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia (NCT00295997) | University of California, San Francisco | 2005-05-01 |
| Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain (NCT00482378) | Mayo Clinic | 2005-03-21 |
| Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00618345) | Mayo Clinic | 2005-03-01 |
| Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer (NCT00104923) | California Cancer Consortium | 2005-02-01 |
| Campath-1H + FK506 and Methylprednisolone for GVHD (NCT00109993) | Case Comprehensive Cancer Center | 2005-01-01 |
| Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma (NCT00258206) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-12-01 |
| Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00134004) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-10-01 |
| Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (NCT00293384) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00301951) | University of California, San Francisco | 2004-09-01 |
| Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00096096) | Fred Hutchinson Cancer Center | 2004-08-01 |
| Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma (NCT00084747) | Jonsson Comprehensive Cancer Center | 2004-06-01 |
| Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer (NCT00134017) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-06-01 |
| Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00227682) | OHSU Knight Cancer Institute | 2004-06-01 |
| G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders (NCT00253552) | OHSU Knight Cancer Institute | 2004-05-01 |
| Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease (NCT00521430) | Asan Medical Center | 2004-04-01 |
| Collecting and Storing Blood Samples From Patients With Cancer (NCT00900120) | University of Medicine and Dentistry of New Jersey | 2004-03-01 |
| T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies (NCT00080925) | National Institutes of Health Clinical Center (CC) | 2004-02-01 |
| Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation (NCT00052884) | Eastern Cooperative Oncology Group | 2004-01-22 |
| Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant (NCT00534118) | Roswell Park Cancer Institute | 2003-10-01 |
| CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant (NCT00369291) | Masonic Cancer Center, University of Minnesota | 2003-09-01 |
| Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma (NCT00937183) | Jan Walewski | 2003-09-01 |
| Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer (NCT00248430) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer (NCT00070382) | Jonsson Comprehensive Cancer Center | 2003-08-01 |
| Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma (NCT00432458) | Mayo Clinic | 2003-07-01 |
| Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy (NCT00066599) | National Cancer Institute (NCI) | 2003-06-01 |
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Epoetin Alfa in Treating Anemia in Patients With Solid Tumors (NCT00058331) | Alliance for Clinical Trials in Oncology | 2003-06-01 |
| Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies (NCT00068523) | Case Comprehensive Cancer Center | 2003-06-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure (NCT00416897) | University of Glasgow | 2003-03-01 |
| Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma (NCT00635154) | Mayo Clinic | 2002-12-01 |
| Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00265837) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-12-01 |
| Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma (NCT00060203) | Case Comprehensive Cancer Center | 2002-12-01 |
| Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma (NCT00049673) | NCIC Clinical Trials Group | 2002-10-15 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00304018) | University of California, San Francisco | 2002-10-01 |
| Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00049374) | University of Maryland, Baltimore | 2002-09-01 |
| Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer (NCT00255710) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-07-01 |
| Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis (NCT00089167) | Memorial Sloan Kettering Cancer Center | 2002-05-01 |
| Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia (NCT00054236) | Case Comprehensive Cancer Center | 2002-05-01 |
| Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (NCT00062231) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-04-01 |
| Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00033332) | National Cancer Institute (NCI) | 2002-04-01 |
| Pyroxamide in Treating Patients With Advanced Cancer (NCT00042900) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders (NCT00053989) | Roswell Park Cancer Institute | 2002-01-29 |
| Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00301912) | University of California, San Francisco | 2002-01-01 |
| Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation (NCT00036712) | Medical College of Wisconsin | 2002-01-01 |
| Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00022607) | California Cancer Consortium | 2002-01-01 |
| Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00045136) | Poniard Pharmaceuticals | 2002-01-01 |
| Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma (NCT00046852) | University of Maryland, Baltimore | 2001-12-01 |
| Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00014508) | Eastern Cooperative Oncology Group | 2001-11-19 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders (NCT00544115) | City of Hope Medical Center | 2001-10-16 |
| Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma (NCT00616720) | Mayo Clinic | 2001-08-01 |
| Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00027560) | Memorial Sloan Kettering Cancer Center | 2001-07-01 |
| Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer (NCT00237627) | UNC Lineberger Comprehensive Cancer Center | 2001-05-01 |
| AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00022282) | AEterna Zentaris | 2001-04-01 |
| Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma (NCT00028886) | Commissie Voor Klinisch Toegepast Onderzoek | 2001-03-01 |
| Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma (NCT00017069) | CTI BioPharma | 2001-02-01 |
| MS-275 in Treating Patients With Hematologic Cancer (NCT00015925) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2001-02-01 |
| Arsenic Trioxide in Treating Patients With Multiple Myeloma (NCT00017433) | CTI BioPharma | 2001-01-01 |
| Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00017602) | Genta Incorporated | 2000-12-01 |
| Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation (NCT00014482) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment (NCT00006348) | Alliance for Clinical Trials in Oncology | 2000-10-01 |
| Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation (NCT00005946) | University of Maryland, Baltimore | 2000-10-01 |
| Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma (NCT00006219) | Mayo Clinic | 2000-08-01 |
| Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma (NCT00008242) | Memorial Sloan Kettering Cancer Center | 2000-08-01 |
| Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma (NCT00008268) | Memorial Sloan Kettering Cancer Center | 2000-08-01 |
| Tipifarnib in Treating Patients With Advanced Hematologic Cancer (NCT00005967) | National Cancer Institute (NCI) | 2000-08-01 |
| Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma (NCT00005987) | Masonic Cancer Center, University of Minnesota | 2000-08-01 |
| Beta Alethine in Treating Patients With Myeloma (NCT00006466) | LifeTime Pharmaceuticals | 2000-08-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma (NCT00006013) | Fox Chase Cancer Center | 2000-06-01 |
| Non-Ablative Allo HSCT For Hematologic Malignancies or SAA (NCT00006379) | Case Comprehensive Cancer Center | 2000-06-01 |
| Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer (NCT00365287) | Masonic Cancer Center, University of Minnesota | 2000-06-01 |
| Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma (NCT00006021) | University of Miami | 2000-06-01 |
| Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer (NCT00006019) | Memorial Sloan Kettering Cancer Center | 2000-05-01 |
| PS-341 in Treating Patients With Hematologic Cancer (NCT00006098) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter (NCT00006083) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma (NCT00014339) | Medsearch | 2000-03-01 |
| Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation (NCT00005606) | Northwestern University | 2000-02-01 |
| Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant (NCT00602706) | Mayo Clinic | 2000-01-01 |
| Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant (NCT00716911) | City of Hope Medical Center | 2000-01-01 |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00005634) | Memorial Sloan Kettering Cancer Center | 2000-01-01 |
| Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer (NCT00004132) | Jonsson Comprehensive Cancer Center | 2000-01-01 |
| 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment (NCT00004239) | Alliance for Clinical Trials in Oncology | 1999-12-01 |
| Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00006042) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-12-01 |
| St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer (NCT00005805) | Memorial Sloan Kettering Cancer Center | 1999-12-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005854) | Fred Hutchinson Cancer Center | 1999-12-01 |
| EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer (NCT00004258) | Indiana University | 1999-12-01 |
| PS-341 in Treating Patients With Advanced Cancer (NCT00006362) | Mayo Clinic | 1999-11-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer (NCT00006225) | Northwestern University | 1999-11-01 |
| Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00044954) | University of Texas Southwestern Medical Center | 1999-11-01 |
| Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia (NCT00612716) | Masonic Cancer Center, University of Minnesota | 1999-10-06 |